Birinapant and Intensity Modulated Re-Irradiation Therapy for Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma
Conditions: Head Cancer; Facial Cancer; Neck Cancer; Upper AerodigestiveTract Cancer; Oral Cancer Interventions: Drug: Birinapant; Radiation: Intensity modulated re-irradiation therapy (IMMRT) Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | HNSCC | Research | Skin Cancer | Squamous Cell Carcinoma